PARAMETRIC PORTFOLIO ASSOCIATES LLC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2015$30,000
+7.1%
17,513
+41.2%
0.00%
Q2 2015$28,000
-34.9%
12,405
-23.2%
0.00%
Q4 2014$43,000
+4.9%
16,148
+18.0%
0.00%
Q3 2014$41,000
-63.4%
13,685
-47.2%
0.00%
Q1 2014$112,000
+72.3%
25,932
+108.5%
0.00%
Q4 2013$65,000
-3.0%
12,435
+18.0%
0.00%
Q3 2013$67,000
+28.8%
10,542
+1.6%
0.00%
Q2 2013$52,00010,3750.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q4 2014
NameSharesValueWeighting ↓
CAXTON CORP 37,069,140$64,500,00087.00%
ARMISTICE CAPITAL, LLC 2,000,000$3,480,0001.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 432,259$752,0000.28%
Geller Advisors LLC 187,323$326,0000.21%
CAXTON CORP 57,000$99,0000.13%
Verity Asset Management, Inc. 64,476$112,0000.11%
TFS CAPITAL LLC 367,364$639,0000.06%
Cutler Capital Management, LLC 72,500$126,0000.06%
LUCAS CAPITAL MANAGEMENT 21,100$37,0000.02%
Nine Chapters Capital Management LLC 129,700$226,0000.02%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders